Susquehanna International Group, LLP Navidea Biopharmaceuticals, Inc. Put Options Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NAVB
# of Institutions
3Shares Held
10.4KCall Options Held
0Put Options Held
0About NAVIDEA BIOPHARMACEUTICALS, INC.
- Ticker NAVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,150,900
- Description
- Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...